Your session is about to expire
← Back to Search
Photosensitizer
PXL-Platinum 330 in Eyes With Corneal Thinning Conditions
Phase 1 & 2
Waitlist Available
Led By Vishal Jhanji, MD
Research Sponsored by Vishal Jhanji
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new way to treat corneal thinning disorders using UV light and a photosensitizer called riboflavin.
Eligible Conditions
- Corneal Atrophy
- Keratoconus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
PXL-Platinum 330 system
Other study objectives
Efficacy measurements by best spectacle-corrected visual acuity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Pulsed lightingExperimental Treatment1 Intervention
Group II: Continuous lightingExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Vishal JhanjiLead Sponsor
1 Previous Clinical Trials
Vishal Jhanji, MDPrincipal InvestigatorUPMC Eye Center
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a condition, like nystagmus, that makes it difficult to keep your eyes still during the treatment or tests.You have a known sensitivity or allergy to the medications used in the study.You have a medical condition that could delay or disrupt the healing process of your skin or other tissues.Your cornea is too thin or misshaped for LASIK or PRK surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Pulsed lighting
- Group 2: Continuous lighting
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.